Lite Strategy, Inc. — Director's Dealing 2020

Jul 27, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2020-07-23

Reporting Person: GOLD DANIEL P PHD (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-23	Common Stock	M	12000	$1.57	Acquired	453632	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-23	Stock Option (Right to Buy)	$1.57	M	12000	Disposed	2025-07-28	Common Stock (275500)	Direct

Footnotes

F1: 80,000 securities consist of restricted stock units, which shall vest on July 2, 2021, one-year anniversary of the date of grant.

F2: All of the options are fully vested and currently exercisable.